Diazepam Dosing for Agitated Hospice Patients
For agitated hospice patients who can swallow, start with lorazepam 0.5-1 mg orally every 4-6 hours as needed (maximum 4 mg/24 hours), reducing to 0.25-0.5 mg in elderly or debilitated patients (maximum 2 mg/24 hours); if unable to swallow, use midazolam 2.5-5 mg subcutaneously every 2-4 hours as needed, with continuous infusion of 10 mg over 24 hours if needed more than twice daily. 1
Important Context: Diazepam Is Not First-Line
The most recent palliative care guidelines do not recommend diazepam as a first-line agent for agitation in hospice settings. 1 The evidence consistently supports shorter-acting benzodiazepines (lorazepam, midazolam) over diazepam due to:
- More predictable pharmacokinetics in elderly and debilitated patients 1
- Easier titration for breakthrough symptoms 1
- Lower risk of accumulation in patients with renal or hepatic impairment 1
If Diazepam Must Be Used
When diazepam is specifically required (e.g., due to formulary restrictions or patient-specific factors), the FDA labeling emphasizes critical precautions: 2
- Debilitated patients require reduced dosing: 2-2.5 mg once or twice daily initially, increased gradually as needed and tolerated 2
- Chronic respiratory insufficiency requires lower doses due to respiratory depression risk 2
- Extreme caution in elderly patients who are especially sensitive to benzodiazepine effects 3
Recommended Benzodiazepine Approach
For Patients Able to Swallow:
- Lorazepam 0.5-1 mg orally every 4-6 hours as needed (maximum 4 mg/24 hours) 1
- Elderly/debilitated: 0.25-0.5 mg (maximum 2 mg/24 hours) 1
- Oral tablets can be used sublingually (off-label) 1
For Patients Unable to Swallow:
- Midazolam 2.5-5 mg subcutaneously every 2-4 hours as needed 1
- If needed frequently (>twice daily), consider continuous subcutaneous infusion starting at 10 mg over 24 hours 1
- Reduce to 5 mg over 24 hours if eGFR <30 mL/min 1
- For palliative sedation, midazolam can be titrated from 0.5-1 mg/hour up to 1-20 mg/hour as continuous infusion 1
When Delirium Is Present
Critical distinction: If agitation is due to delirium rather than pure anxiety, benzodiazepines can worsen symptoms. 1
First-line for delirium with agitation:
- Haloperidol 0.5-1 mg orally/subcutaneously every 2 hours as needed (maximum 10 mg daily, or 5 mg daily in elderly) 1
- Add benzodiazepine only if agitation persists despite adequate neuroleptic dosing 1
Alternative antipsychotics:
- Levomepromazine 12.5-25 mg subcutaneously (6.25-12.5 mg in elderly), up to 300 mg/day continuous infusion 1
- Chlorpromazine 12.5 mg IV/IM every 4-12 hours or 25-100 mg rectally 1
Common Pitfalls to Avoid
- Do not use benzodiazepines as initial treatment for delirium without neuroleptics, as this can cause paradoxical agitation 1, 2
- Avoid abrupt discontinuation in patients already on benzodiazepines, as this risks seizures and severe withdrawal 2, 4
- Do not combine with opioids without careful monitoring due to synergistic respiratory depression risk 2
- Recognize that caregiver distress often drives prescribing decisions rather than patient symptoms alone 5
Dose Escalation Strategy
If initial benzodiazepine doses are inadequate: 1
- Ensure reversible causes are addressed (pain, urinary retention, constipation, hypoxia) 1
- Add or optimize neuroleptic before escalating benzodiazepine 1
- Consider continuous infusion if requiring frequent breakthrough doses 1
- For refractory cases, high-dose neuroleptics (chlorpromazine up to 2000 mg/day oral or olanzapine >200 mg/day sublingual) have been reported effective 6
Special Considerations
- Paradoxical agitation can occur with benzodiazepines, particularly in elderly patients—if this develops, discontinue and switch to neuroleptic 2, 4
- Tolerance develops with prolonged use, requiring dose escalation 1, 4
- Hospice setting matters: nursing home hospice patients face unique challenges requiring individualized approaches 5